CohortBid connects clinical trial sites and SMOs across India with pharma sponsors and CROs. Discover open trials, bid with your patient cohort, and complete the full site selection workflow — digitally and compliantly.
Trusted by teams at
Nearly half of all selected clinical sites fail to enroll a single patient, necessitating emergency site rescue.
Eight out of ten clinical trials face timeline extensions due to inaccurate investigator feasibility projections.
Paper CDAs and manual emails drag out the Site Selection Visit (SSV) cycles to over 3 months per protocol.
Investigators submit live registry snapshots verified by CTRI history, drastically reducing zero-enrollment sites.
Consolidated digital workflows (21 CFR Part 11 CDAs and multi-step digital FQs) select sites in days.
Real-time matching of CDSCO numbers ensures investigators hold valid Ethics Committee clearances.
Purpose-built workflows mapping feasibility and protocol designs across stakeholders.
Accelerate trial timelines by identifying pre-verified sites with matching patient registries, eliminating feasibility failure rates.
Promote your clinical facility directly to global sponsors, secure trial bid invitations, and sign CDAs electronically.
Centrally coordinate trial bidding, track GCP certification expiries, and manage feasibility submissions for connected clinics.
Our verified site database covers major clinical indications with deep historical research records.
CohortBid's proprietary SSV (Site Selection Visit) Predictive Engine optimizes CRO site selection cycles by 70%, matching patient cohorts and ethics committee registries automatically to predict and secure enrollment.
CRO or sponsor publishes non-confidential trial details — indication, phase, sites needed, patient criteria, and deadline. No protocol shared yet.
Investigators browse listings matched to their specialty and submit an Expression of Interest — patient cohort data, trial experience, and site capability.
Shortlisted sites sign a digital CDA. Protocol details are unlocked. 21 CFR Part 11 compliant e-signature with full audit trail — no paper.
Sites complete Basic FQ and Protocol FQ online. Sponsor scores, shortlists, and generates a sponsor-ready PDF report. Sites confirmed.
Search 1,200+ verified investigators by therapeutic area, city, IEC status, phase experience, and audit history. CTRI and ClinicalTrials.gov data included.
Sponsors post open trial listings. Sites discover and bid with patient cohort data. Auto-scored bids ranked by eligibility, experience, and IEC status.
Built-in CDA templates with merge fields. Investigators sign electronically. Full 21 CFR Part 11 audit trail — timestamp, IP address, document hash.
Digital Basic FQ (39 questions) and Protocol FQ (32 questions) submitted on platform. Multi-role access, auto-scored evaluation, and instant shortlisting.
Compliant with CDSCO GCP, G.S.R. 227(E) New Drugs rules, 21 CFR Part 11, and DPDPA Act 2023. Complete cryptographic signatures and document audit logs.
Coordinate trials across your entire site network. Assign studies, trace ethics approvals, and review digital signatures centrally.
CohortBid enforces strict data protection architectures aligned with Indian and global healthcare IT regulations.
Complies strictly with India's Digital Personal Data Protection Act 2023. Site capacities, equipment logs, and CRC coordinates are consent-locked and never shared with sponsors without explicit investigator authorisation.
Enforces full regulatory audit trails, secure electronic signatures, system-generated date stamps, and cryptographic document locks for digital CDAs, ensuring international regulatory alignment.
Validates clinical investigators' GCP certifications and Ethics Committee registration validity. Aligns with standard risk-based quality management principles during site selection.
Takes 5 minutes. Instant verification of CDSCO registration and CTRI experience database matching.
Everything you need to know about the CohortBid clinical operations portal.
No, registration and profile listing are completely free for clinical trial sites and Site Management Organisations (SMOs). Sponsors fund the marketplace operations via protocol publication and analytics service access.
CohortBid is built in strict compliance with the Digital Personal Data Protection Act (DPDPA) 2023. Site-level parameters (Ethics Committee registries, bed counts, CRC contacts) are fully encrypted and only visible to Sponsors once the Investigator signs a mutual CDA and clicks "Share Profile" for a specific trial invitation.
Yes. All electronic signatures and document vaults are fully compliant with USFDA 21 CFR Part 11 and Indian Information Technology (IT) Act, 2000. Every signed CDA generates a unique cryptographic audit log containing IP coordinates, email validation hashes, and date-time stamps.
Sponsor searches run parallel queries against local CDSCO registries and live APIs from ClinicalTrials.gov and Clinical Trials Registry - India (CTRI). When matches are found in the global registries, sponsors can shortlist them to import the registry parameters directly into the local database workspace.